Generative AI in Pharma Market to Exceed USD 2,258.1 Mn by 2033, with 31.2% CAGR | Marketresearch.bi

Marketresearch.biz reports that the Generative AI in Pharma market size is expected to be worth around USD 2258.1 Mn by 2033 from USD 159.9 Mn in 2023, growing at a CAGR of 31.2% during the forecast period from 2024 to 2033.Overview of the Generative AI in Pharma MarketGenerative AI in pharma revolutionizes drug dis...

Related Keywords

India ,Germany ,Russia ,Israel ,United States ,United Kingdom ,South Korea ,New York ,China ,Switzerland ,Ukraine ,America ,Asia Pacific ,Lawrence John ,Xar Incorporated ,Atomwise Inc ,Clinical Trial Research ,Arctoris Ltd ,Prudour Pvt Ltd ,Recursion Pharmaceuticals ,Cloud Pharmaceuticals ,Numedii Inc ,Cyclica Inc ,Including Full ,Click Here ,Sample Report ,Drug Discovery ,Target Specificity ,Novel Therapies ,Generative Ai In Pharma Market ,Global Generative Ai In Pharma Market ,Key Segments Are Covered ,Language Processing ,Key Players ,Generative Ai In Pharma ,North America ,Middle East ,More Information ,Players Analysis ,Compliance Insights ,Impact Analysis ,Russia Ukraine War ,Powered By Prudour ,York City ,